{"title":"Does Compression of the Fourth Ventricle Cause Preterm Labor? Analysis of Data From the PROMOTE Study","authors":"Kendi Hensel, Brandy M. Roane","doi":"10.7556/jaoa.2019.114","DOIUrl":null,"url":null,"abstract":"Abstract Background The technique for the compression of the fourth ventricle (CV4) in the brain has been described as a method of reaching the physiologic centers that reside in its floor and of restoring optimal flow of the cerebrospinal fluid. However, a study published as an abstract in 1992 questioned whether CV4, when applied to pregnant women, could induce uterine contractions and possibly labor. Objective To further examine whether CV4 could induce uterine contractions and labor as part of the osteopathic manipulative treatment (OMT) protocol used in the Pregnancy Research in Osteopathic Manipulation Optimizing Treatment Effects (PROMOTE) study. Methods Labor and delivery data collected during the PROMOTE study from 2007-2011 were analyzed. The PROMOTE study was funded by the National Institutes of Health and was a randomized controlled clinical trial that measured the primary outcomes of back-specific functioning and pain in pregnant women aged 18 to 34 years. Participants were randomly divided into 3 groups—usual obstetric care only, placebo ultrasound treatment plus usual obstetric care, and OMT plus usual obstetric care. Study participants were scheduled for 7 treatment visits. Presented data were gathered from labor and delivery records. Results Four hundred participants were included. No significant differences were identified between treatment groups for the development of high-risk status (P=.293) or preterm delivery (P=.673). Evaluation of high-risk status by preterm delivery for the groups also showed no significant differences between groups (P=.455). Conclusion The application of CV4 as part of an OMT protocol during the third trimester caused neither a higher incidence of preterm labor nor the development of high-risk status.","PeriodicalId":16639,"journal":{"name":"Journal of Osteopathic Medicine Journal of Osteopathic Medicine","volume":"279 1","pages":"668 - 672"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Osteopathic Medicine Journal of Osteopathic Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7556/jaoa.2019.114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Abstract Background The technique for the compression of the fourth ventricle (CV4) in the brain has been described as a method of reaching the physiologic centers that reside in its floor and of restoring optimal flow of the cerebrospinal fluid. However, a study published as an abstract in 1992 questioned whether CV4, when applied to pregnant women, could induce uterine contractions and possibly labor. Objective To further examine whether CV4 could induce uterine contractions and labor as part of the osteopathic manipulative treatment (OMT) protocol used in the Pregnancy Research in Osteopathic Manipulation Optimizing Treatment Effects (PROMOTE) study. Methods Labor and delivery data collected during the PROMOTE study from 2007-2011 were analyzed. The PROMOTE study was funded by the National Institutes of Health and was a randomized controlled clinical trial that measured the primary outcomes of back-specific functioning and pain in pregnant women aged 18 to 34 years. Participants were randomly divided into 3 groups—usual obstetric care only, placebo ultrasound treatment plus usual obstetric care, and OMT plus usual obstetric care. Study participants were scheduled for 7 treatment visits. Presented data were gathered from labor and delivery records. Results Four hundred participants were included. No significant differences were identified between treatment groups for the development of high-risk status (P=.293) or preterm delivery (P=.673). Evaluation of high-risk status by preterm delivery for the groups also showed no significant differences between groups (P=.455). Conclusion The application of CV4 as part of an OMT protocol during the third trimester caused neither a higher incidence of preterm labor nor the development of high-risk status.
摘要背景:压缩大脑第四脑室(CV4)的技术被描述为一种到达位于其底部的生理中心并恢复脑脊液最佳流动的方法。然而,1992年作为摘要发表的一项研究质疑,当CV4应用于孕妇时,是否会导致子宫收缩和可能的分娩。目的进一步探讨CV4作为骨科手法治疗(OMT)方案的一部分是否能诱导子宫收缩和分娩,并应用于骨科手法优化治疗效果(PROMOTE)的妊娠研究。方法对2007-2011年在PROMOTE研究中收集的分娩资料进行分析。PROMOTE研究由美国国立卫生研究院(National Institutes of Health)资助,是一项随机对照临床试验,测量了18至34岁孕妇背部特定功能和疼痛的主要结果。参与者随机分为3组:常规产科护理组、安慰剂超声治疗加常规产科护理组和OMT加常规产科护理组。研究参与者被安排进行7次治疗访问。所呈现的数据来自分娩和分娩记录。结果共纳入400人。在高危状态(P=.293)或早产(P=.673)方面,治疗组间无显著差异。两组间通过早产评估高危状态也无显著差异(P=.455)。结论在妊娠晚期应用CV4作为OMT方案的一部分既不会导致早产的发生率升高,也不会导致高危状态的发展。